Massive hepatic necrosis (MHN) represents the most severe pathological form of acute liver failure (ALF), with high mortality ...
Can organ-on-a-chip technology solve drug development’s biggest challenge—poor clinical success rates? Dr. Lorna Ewart ...
Comprehensive review led by R3’s Department of Research consolidates emerging evidence on Wharton’s jelly function, ...
ProQR Therapeutics is a high-potential, early-stage RNA editing platform company, but remains pre-proof-of-mechanism in ...
Precision BioSciences, Inc. (DTIL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 9:30 AM EDTCompany ParticipantsJohn Kelly - CFO ...
Morning Overview on MSN
One-time gene-editing treatment lowers LDL cholesterol in early trial
A single infusion of a CRISPR-based gene-editing therapy was associated with reductions in LDL cholesterol and triglycerides in patients with hard-to-treat lipid disorders, according to results from a ...
Health and Me on MSN
Liver disease: Expert says eating right can reverse inflammation
In today’s fast-paced world, where stress and stimulation dominate, caring for the liver has never been more essential.
Trp, studied under names such as Thymogen or Thymagen, represents a short peptide bioregulator derived from the ...
8hon MSN
Your liver is hiding a shifting cellular map, and diet can rapidly redraw its internal landscape
As we go about our day, the trillions of cells in our bodies run like well-oiled machines: continually sensing what's happening around them and making modifications to keep us humming along. Like ...
A new liver tissue engineering strategy called BOOST could help bridge the transplant gap for thousands of end-stage liver ...
Scientists are rethinking how to treat a widespread genetic cholesterol disorder by targeting particle production instead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results